So, Ponatinib is a BCR-ABL inhibitor, used for treating two types of cancer—CML and Ph ALL—and it’s used for folks who can’t handle their old TKI treatments. It’s actually a multi-kinase inhibitor, meaning it goes after a bunch of different kinases, which are like the bad guys in cancer cell growth. You can get this drug in two strengths—there’s a 15 mg one and a 45 mg one, both in that film-coated tablet form.
The usual dose is 45 mg, taken once every day, and you can take it with or without food. The tablets come in bottles, and each bottle has 30 of them.
